Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies.doi:10.1203/00006450-201011001-01050Urbina, E CFátima, M C PHerrera, J C SPediatric Research
[-j] [-n] [-s] [-t] filename… description options acctcms reads one or more filenames, normally in the form described in acct(3head). it adds all records for processes that executed identically named commands, sorts them, and writes them to the standard output, normally using an ...
United States Patent Application 20220275092 Kind Code: A1 Abstract: The application relates to dosage regimes for the administration of an antibody molecule which binds programmed death-ligand 1 (PD-L1) and lymphocyte-activation gene 3 (LAG-3) and their medical use in the treatment of cancer in...
DUCHENE et al., Pharmaceutical and medical aspects of bioadhesive systems for drug administration, in Drug. Dev. Ind. Pharm. 14 (2 & 3), 283-318(1988) and J. M. GU et al., Binding of acrylic polymers to mucin/epithelial surfaces, structure-property relationships, in CRC Crit. Rev. ...
Effects of Different Routes of Local Anesthetic Administration in Epidural Anesthesia for Transurethral Resection of the ProstateASA I-III 60 patients were enrolled in the study. Patients were randomized into the following three groups: in Group N (needle), total volume of local anesthetic (16 mL)...
Pedersen CA, Schneider PJ, Santell JP et al. ASHP national survey of pharmacy practice in acute care settings: monitoring, patient education, and wellness--2000. Am J Health-Syst Pharm. 2000; 57:2171- 87.Ringold DJ, Santell JP, Schneider PJ et al. ASHP nation...
We did not calculate aOR in these patients since VTE/PE might have been the indication for IVIG use and likely occurred before the use of IVIG. In AIHA, there were 80 VTE/PE cases against 1050 patients, accounting for 7.62%, with an aOR of 2.62 and a 95% CI of 1.95-3.51, with p...
It is the 1300 K free-piston Stirling power conversion system that is the ultimate goal. The first two phases of this program, the 650 K SPDE and the 1050 K SSE are emphasized.Slaby, J. GNational Aeronautics and Space Administration
17. J. Wood et al. Cancer Research 60 (2000), 2178. 18. K. LaMontagne et al. Cancer Res. 66 (2006), 221.Previous Patent: Short Interfering Ribonucleic Acid (siRNA) for Oral AdministrationNext Patent: RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression ...
among others. The expression of IL-22 mRNA was originally identified in IL-9 simulated T cells and mast cells in murine, as well as Concanavilin A (Con A) stimulated spleen cells (Dumoutier, et al., J. Immunology, 164:1814-1819, 2000). The human IL-22 mRNA is mainly expressed in...